Kyverna Therapeutics is positioned to pioneer the autoimmune CAR T space. Click here to see why KYTX stock is a Buy.
Chief Executive Alex Karp’s recent broadside against the frontier model vendors put a knife to the throat of the central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results